Category Archives: Most Popular

News From 3 Top Internet Stocks Rated This Week

By Sarah Roden From lawsuits to mergers, Internet stocks had a busy week. Find out what analysts are saying about 3 of the most popular Internet stocks: Google (NASDAQ: GOOGL) This week, the European Union formally accused Google of antitrust

Prescription Data Offers Insight Into Gilead Sciences, Inc. Sales

By Sarah Roden Gilead Sciences, Inc. (NASDAQ: GILD) received new data from IMS Health about the breakdown of its drug prescriptions. Gilead is most known for its hepatitis C medications, Harvoni and Sovaldi. IMS prescription data breaks down how many

Upcoming Events in Biotechnology

By Sarah Roden On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for: OvaScience Inc (NASDAQ: OVAS): In mid-April, OvaScience anticipates the first live births from their

Roth Capital Weighs in on 5 Biotech Stocks to Watch

By Sarah Roden As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.” Though the analyst rates 15 biotech stocks, we have highlighted

What Does FXCM Management Know That Investors Don’t?

By Carly Forster and Sarah Roden Shares of FXCM (NYSE: FXCM) shot up 6.5% in after-hours trading on Thursday, March 12th after the company announced its fourth quarter earnings and updated investors on efforts to repay Leucadia National Corporation (NYSE:

8 Strong Recommendations for 2015

By Carly Forster 2014 was an eventful year on Wall Street with many ups and downs. Now that 2015 is here, many investors have been wondering which stocks they should jump on and which stocks they should avoid. But how